Publikatsioonide andmebaasi aluseks on rahvusvahelised andmebaasid Medline (OVID), Web of Science, Scopus, EBSCO ja ajakiri Eesti Arst. On kogutud ka andmeid teistest eesti ajakirjadest ning internetist. Kirjetes on andmed autori nime, artikli pealkirja ja allika kohta, kus on artikkel ilmunud.
Linkida on võimalik publikatsioonide sisukokkuvõtetele, kui need on olemas PubMed-is. Publikatsioonid on liigitatud ETIS-e klassifikaatorite järgi. Otsida on võimalik autori, publikatsiooni pealkirja ja aasta järgi.
Andmebaasi täiendatakse jooksvalt ja parandatakse ning lisatakse uusi andmeid vanadesse aastakäikudesse. Palun täiendused, parandused ja ettepanekud saata aadressile Keiu.Saarniit@kliinikum.ee

2019.a. publikatsioonid

Kokku publikatsioone: 129

Artiklid rahvusvahelistes ajakirjades
1Abilleira S., de Sousa DA., Gattringer T., Kobayashi A., Fazekas F., Szikora I., Feigin V., Caso V., Gallofre M., Fischer U., ESO/ESMINT/EAN/SAFE Survey on Stroke Care Collaborators
Autorite grupp:Kõrv J., Vibo R., Malikov V.
Planning of stroke care and urgent prehospital care across Europe: Results of the ESO/ESMINT/EAN/SAFE Survey
PUBMED
European Stroke Journal: 4 (4), 329-336, 2019
2Ah R., BChir MB., Cao Y., Geijer H., Taha K., Pourhossein-Sarmeh S., Talving P., Ljungqvist O., Mohseni S.
Prognostic Value of P-POSSUM and Osteopenia for Predicting Mortality After Emergency Laparotomy in Geriatric Patients
PUBMED
Bulletin of Emergency And Trauma: 7 (3), 223-231, 2019
3Alver M., Palover M., Saar A., Läll K., Zekavat SM., Tõnisson N., Leitsalu L., Reigo A., Nikopensius T., Ainla T., Kals M., Mägi R., Gabriel SB., Eha J., Lander ES., Irs A., Philippakis A., Marandi T., Natarajan P., Metspalu A., Kathiresan S., Esko T.
Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
PUBMED
Genetics in Medicine: 21 (5), 1173-1180, 2019
4Asser A., Kõks S., Soomets U., Terasmaa A., Sauk M., Eltermaa M., Piip P., Ubhayasekera K., Bergquist J., Taba P.
Acute effects of methcathinone and manganese in mice: A dose response study
PUBMED
Heliyon: 5 (9), Artikkel nr e02475, 2019
5Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies
Autorite grupp:Viigimaa M.
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
PUBMED
Atherosclerosis: 290, 140-205, 2019
6Bachelot T., Ciruelos E., Schneeweiss A., Puglisi F., Peretz-Yablonski T., Bondarenko I., Paluch-Shimon S., Wardley A., Merot JL., du Toit Y., Easton V., Lindegger N., Miles D., PERUSE investigators
Autorite grupp:Kütner R., Padrik P.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
PUBMED
Annals of Oncology: 30 (5), 766-773, 2019
7Banach M., Bruckert E., Descamps OS., Ellegard L., Ezhov M., Föger B., Fras Z., Kovanen PT., Latkovskis G., März W., ..., Viigimaa M.
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
PUBMED
Atherosclerosis Supplements: 39, e1-e8, 2019
8Brilakis ES., Mashayekhi K., Tsuchikane E., Abi Rafeh N., Alaswad K., Araya M., Avran A., Azzalini L., Babunashvili AM., Bayani B., ..., Laanmets P.
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
PUBMED
Circulation: 140 (5), 420-433, 2019
9Burtness B., Harrington KJ., Greil R., Soulieres D., Tahara M., de Castro G. Jr., Psyrri A., Baste N., Neupane P., Bratland A., ..., KEYNOTE-048 Investigators
Autorite grupp:Jürgens H., Putnik K.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
PUBMED
The Lancet: 394 (10212), 1915-1928, 2019
10Collij LE., Konijnenberg E., Reimand J., Kate MT., Braber AD., Alves IL., Zwan M., Yaqub M., van Assema DME., Wink AM., Lammertsma AA., Scheltens P., Visser PJ., Barkhof F., van Berckel BNM.
Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
PUBMED
Journal of Nuclear Medicine: 60 (4), 541-547, 2019
11Cortegiani A., Gregoretti C., Neto AS., Hemmes SNT., Ball L., Canet J., Hiesmayr M., Hollmann MW., Mills GH., Melo MFV., Putensen C., Schmid W., Severgnini P., Wrigge H., Gama de Abreu M., Schultz MJ., Pelosi P., LAS VEGAS Investigators, PROVE Network, Clinical Trial Network of the European Society of Anaesthesiology
Autorite grupp:Herodes E., Kivik P., Oganjan J., Aun A., Sõrmus A., Sarapuu K., Mäll M., Karjagin J.
Association between night-time surgery and occurrence of intraoperative adverse events and postoperative pulmonary complications
PUBMED
British Journal of Anaesthesia: 122 (3), 361-369, 2019
12de Wilde A., Reimand J., Teunissen CE., Zwan M., Windhorst AD., Boellaard R., van der Flier WM., Scheltens P., van Berckel BNM., Bouwman F., Ossenkoppele R.
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
PUBMED
Alzheimer's Research ja Therapy: 11 (1), Artikkel nr 78, 2019
13Diener HC., Sacco RL., Easton JD., Granger CB., Bernstein RA., Uchiyama S., Kreuzer J., Cronin L., Cotton D., Grauer C., ..., RE-SPECT ESUS Steering Committee and Investigators
Autorite grupp:Kõrv J., Schneider S.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
PUBMED
New England Journal of Medicine: 380 (20), 1906-1917, 2019
14Einberg M., Saar S., Seljanko A., Lomp A., Lepner U., Talving P.
Cardiac Injuries at Estonian Major Trauma Facilities: A 23-year Perspective
PUBMED
Scandinavian Journal of Surgery: 108 (2), 159-163, 2019
15Einstein S., Pilt K., Palmar M., Meigas K., Viigimaa M.
Aortic Augmentation Index is Dependent on Bodyside in Healthy Young Subjects
PUBMED
High Blood Pressure & Cardiovascular Prevention: 26 (5), 375-382, 2019
16Farmakis D., Agostoni P., Baholli L., Bautin A., Comin-Colet J., Crespo-Leiro MG., Fedele F., Garcia-Pinilla JM., Giannakoulas G., Grigioni F., ..., Põder P.
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
PUBMED
International Journal of Cardiology: 297, 83-90, 2019
17Frigoli E., Smits P., Vranckx P., Ozaki Y., Tijssen J., Jüni P., Morice MC., Onuma Y., Windecker S., Frenk A., Spaulding C., Chevalier B., Barbato E., Tonino P., Hildick-Smith D., Roffi M., Kornowski R., Schultz C., Lesiak M., Iniguez A., Colombo A., Alasnag M., Mullasari A., James S., Stankovic G., Ong PJL., Rodriguez AE., Mahfoud F., Bartunek J., Moscovitis A., Laanmets P., Leonardi S., Heg D., Sunnaker M., Valgimigli M.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation with an abbreviated versus standard DAPT regimen (MASTER DAPT) study
PUBMED
American Heart Journal: 209, 97-105, 2019
18Galli E., Planken A., Kadastik-Eerme L., Saarma M., Taba P., Lindholm P.
Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson's Disease
PUBMED
Frontiers in Neuroscience: 13, Artikkel nr 929, 2019
19Global Surgical Outcomes (GlobalSurg) Collaboration
Autorite grupp:Talving P.
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy
PUBMED
British Journal of Surgery: 106 (2), E103-E112, 2019
20Gonzalez-Alvaro I., Castrejon I., Carmona L., ACT-RAY PROAR and EMECAR study groups
Autorite grupp:Pärsik E.
The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity
PUBMED
PLoS ONE: 14 (4), Artikkel nr e0214717, 2019
21Goodman SG., Aylward PE., Szarek M., Chumburidze V., Bhatt DL., Bittner VA., Diaz R., Edelberg JM., Hanotin C., Harrington RA., ..., Viigimaa M.
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
PUBMED
Journal of the American College of Cardiology: 74 (9), 1177-1186, 2019
22Innos K., Oselin K., Laisaar T., Aareleid T.
Patterns of survival and surgical treatment in lung cancer patients in Estonia by histologic type and stage, 1996-2016
PUBMED
Acta Oncologica: 58 (11), 1549-1556, 2019
23Jukema JW., Szarek M., Zijlstra LE., de Silva HA., Bhatt DL., Bittner VA., Diaz R., Edelberg JM., Goodman SG., Hanotin C., Harrington RA., Karpov Y., Moryusef A., Pordy R., Prieto JC., Roe MT., White HD., Zeiher AM., Schwartz GG., Steg PG., ODYSSEY OUTCOMES Committees and Investigators
Autorite grupp:Viigimaa M., Soopõld Ü.
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
PUBMED
Journal of the American College of Cardiology: 74 (9), 1167-1176, 2019
24Jürgenson J., Serg M., Kampus P., Kals J., Muda P., Zagura M., Viru M., Zilmer M., Eha J., Unt E.
The effect of pre-seasonal strength training on central hemodynamics and cardiac function in elite powerlifting athletes
Research Reports in Clinical Cardiology: 10, 33-41, 2019
25Jürgenson J., Serg M., Kampus P., Kals J., Zagura M., Viru M., Zilmer K., Zilmer M., Eha J., Unt E.
Oxidative Stress Parameters and Its Associations With Arterial Stiffness in Competitive Powerlifting Athletes After 12-Week Supervised Strength Training
PUBMED
Journal of Strength and Conditioning Research: 33 (7), 1816-1822, 2019
26Kalle S., Tanner R., Luman M., Fridolin I.
Free Pentosidine Assessment Based on Fluorescence Measurements in Spent Dialysate
PUBMED
Blood Purification: 47 (1-3), 85-93, 2019
27Kirmeier E., Eriksson LI., Lewald H., Jonsson Fagerlund M., Hoeft A., Hollmann M., Meistelman C., Hunter JM., Ulm K., Blobner M., POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe (POPULAR) Contributors
Autorite grupp:Elme A., Karjagin J., Sõrmus A., Toim H.
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study
PUBMED
The Lancet Respiratory Medicine: 7 (2), 129-140, 2019
28Kollef MH., Novacek M., Kivistik Ü., Rea-Neto A., Shime N., Martin-Loeches I., Timsit JF., Wunderink RG., Bruno CJ., Huntington JA., Lin G., Yu B., Butterton JR., Rhee EG.
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
PUBMED
The Lancet Infectious Diseases: 19 (12), 1299-1311, 2019
29Konert T., Vogel WV., Paez D., Polo A., Fidarova E., Carvalho H., Duarte PS., Zuliani AC., Santos AO., Altuhhova D., Karusoo L., ...
Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial
PUBMED
European Journal of Nuclear Medicine and Molecular Imaging: 46 (11), 2235-2243, 2019
30Kurvits L., Reimann E., Kadastik-Eerme L., Truu L., Kingo K., Erm T., Kõks S., Taba P., Planken A.
Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson's Disease Patients
PUBMED
Frontiers in Neuroscience: 13, Artikkel nr 13, 2019
31Miro O., Dargan PI., Wood DM., Dines AM., Yates C., Heyerdahl F., Hovda KE., Giraudon I., Euro-DEN Plus Research Group, Galicia M.
Autorite grupp:Paasma R., Põld K.
Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases
PUBMED
Clinical Toxicology: 57 (8), 718-726, 2019
32Mohseni S., Ivarsson J., Ahl R., Dogan S., Saar S., Reinsoo A., Sepp T., Isand KG., Garder E., Kaur I., Ruus H., Talving P.
Simultaneous common bile duct clearance and laparoscopic cholecystectomy: experience of a one-stage approach
PUBMED
European Journal of Trauma and Emergency Surgery: 45 (2), 337-342, 2019
33Montagna G., Anderson D., Bochenek-Cibor J., Bozovic-Spasojevic I., Campos C., Cavallero S., Durutovic I., Gomez Cuadra MO., Irfan T., Joly L., Kassem L., Kolben TM., Machacek M., Mir Khan B., Nagvekar M., Pellegrino B., Pogoda K., Camara GR., Ferreira PS., Seferi M., Talibova N., Van den Rul N., Vettus E., Rocco N.
How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2)
PUBMED
Breast: 43, 18-21, 2019
34Oselin K., Girard N., Lepik K., Adamson-Raieste A., Vanakesa T., Almre I., Leismann T., Chalabreysse L.
Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience
PUBMED
Journal of Thoracic Disease: 11 (2), 456-464, 2019
35Otsa K., Tälli S., Harding P., Pärsik E., Esko M., Teepere A., Tammaru M.
Administrative database as a source for assessment of systemic lupus erythematosus prevalence: Estonian experience
PUBMED
BMC Rheumatology: 3, Artikkel nr 26, 2019
36Paalme V., Rump A., Mädo K., Teras M., Truumees B., Aitai H., Ratas K., Bourge M., Chiang CS., Ghalali A., Tordjmann T., Teras J., Boudinot P., Kanellopoulos JM., Rüütel Boudinot S.
Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
PUBMED
Frontiers in Immunology: 10, Artikkel nr 2074, 2019
37Padar M., Reintam Blaser A., Talving P., Lipping E., Starkopf J.
Abdominal compartment syndrome: Improving outcomes with a multidisciplinary approach - a narrative review
Journal of Multidisciplinary Healthcare: 12, 1061-1074, 2019
38Pollesello P., Ben Gal T., Bettex D., Cerny V., Comin-Colet J., Eremenko AA., Farmakis D., Fedele F., Fonseca C., Harjola VP., ..., Põder P.
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure - Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
PUBMED
Journal of Clinical Medicine: 8 (11), Artikkel nr 1834, 2019
39Popov SV., Skryabin ON., Orlov IN., Suleymanov MM., Krõševskaja A., Obidnyak VM.
Comparative analysis of results in laparoscopic radical cystectomy with extracorporeal and intracorporeal neobladder formation
PUBMED
Urologiia: 1, 68-72, 2019
40Rahu M., Kartus JT., Põldoja E., Kolts I., Kask K.
Hill-Sachs Remplissage Procedure Based on Posterosuperior Capsulomuscular Anatomy
PUBMED
Arthroscopy Techniques: 8 (6), e623-e627, 2019
41Ray KK., Colhoun HM., Szarek M., Baccara-Dinet M., Bhatt DL., Bittner VA., Budaj AJ., Diaz R., Goodman SG., Hanotin C., Harrington RA., Jukema JW., Loizeau V., Lopes RD., Moryusef A., Murin J., Pordy R., Ristic AD., Roe MT., Tunon J., White HD., Zeiher AM., Schwartz GG., Steg PG.,ODYSSEY OUTCOMES Committees and Investigators
Autorite grupp:Viigimaa M., Soopõld Ü.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
PUBMED
The Lancet Diabetes & Endocrinology: 7 (8), 618-628, 2019
42Reimand J., de Wilde A., Teunissen CE., Zwan M., Windhorst AD., Boellaard R., Barkhof F., van der Flier WM., Scheltens P., van Berckel BNM., Ossenkoppele R., Bouwman F.
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
PUBMED
Alzheimer's Research ja Therapy: 11 (1), Artikkel nr 100, 2019
43Roe MT., Li QH., Bhatt D., Bittner VA., Diaz R., Goodman SG., Harrington RA., Jukema JW., Lopez-Jaramillo P., Lopes RD., Louie MJ., Moriarty PM., Szarek M., Vogel R., White HD., Zeiher AM., Baccara-Dinet MT., Steg PG., Schwartz GG.
Autorite grupp:Viigimaa M., Soopõld Ü.
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
PUBMED
Circulation: 140 (19), 1578-1589, 2019
44Saar A., Läll K., Alver M., Marandi T., Ainla T., Eha J., Metspalu A., Fischer K.
Estimating the performance of three cardiovascular disease risk scores: The Estonian Biobank cohort study
PUBMED
Journal of Epidemiology and Community Health: 73 (3), 272-277, 2019
45Saar S., Mihnovitš V., Lustenberger T., Rauk M., Noor EH., Lipping E., Isand KG., Lepp J., Lomp A., Lepner U., Talving P.
Twenty-four hour versus Extended Antibiotic Administration After Surgery in Complicated Appendicitis: A Randomized Controlled Trial
PUBMED
Journal of Trauma and Acute Care Surgery: 86 (1), 36-42, 2019
46Sammul S., Jensen-Urstad M., Johansson J., Lenhoff H., Viigimaa M.
Psychosocial Factors and Personality Traits and the Prevalence of Arterial Hypertension Among 35- and 55-Year-Old Men and Women in Sweden and Estonia: a SWESTONIA Longitudinal Study
PUBMED
High Blood Pressure & Cardiovascular Prevention: 26 (6), 475-482, 2019
47Sands BE., Peyrin-Biroulet L., Loftus EV. Jr., Danese S., Colombel JF., Törüner M., Jonaitis L., Abhyankar B., Chen J., Rogers R., Lirio RA., Bornstein JD., Schreiber S., VARSITY Study Group
Autorite grupp:Kull K., Borissova J.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
PUBMED
New England Journal of Medicine: 381 (13), 1215-1226, 2019
48Sartelli M., Abu-Zidan FM., Labricciosa FM., Kluger Y., Coccolini F., Ansaloni L., Leppäniemi A., Kirkpatrick AW., Tolonen M., ..., Ümarik T.
Physiological parameters for Prognosis in Abdominal Sepsis (PIPAS) Study: a WSES observational study
PUBMED
World Journal of Emergency Surgery: 14, Artikkel nr 34, 2019
49Schmidinger M., Bamias A., Procopio G., Hawkins R., Sanchez AR., Vazquez S., Srihari N., Kalofonos H., Bono P., Pisal CB., Hirschberg Y., Dezzani L., Ahmad Q., Jonasch E., PRINCIPAL Study Group
Autorite grupp:Mägi A., Pokker H.
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
PUBMED
Oncologist: 24 (4), 491-497, 2019
50Sillat T., Parkkinen M., Lindahl J., Mustonen A., Mäkinen TJ., Madanat R., Koskinen SK.
Fibular head avulsion fractures accompanying operative treated medial tibial plateau fractures
PUBMED
Skeletal Radiology: 48 (9), 1411-1416, 2019
51Szarek M., White HD., Schwartz GG., Alings M., Bhatt DL., Bittner VA., Chiang CE., Diaz R., Edelberg JM., Goodman SG., ..., ODYSSEY OUTCOMES Committees and Investigators
Autorite grupp:Viigimaa M., Soopõld Ü.
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
PUBMED
Journal of the American College of Cardiology: 73 (4), 387-396, 2019
52Steg PG., Szarek M., Bhatt DL., Bittner VA., Bregeault MF., Dalby AJ., Diaz R., Edelberg JM., Goodman SG., Hanotin C., Harrington RA., Jukema JW., Lecorps G., Mahaffey KW., Moryusef A., Ostadal P., Parkhomenko A., Pordy R., Roe MT., Tricoci P., Vogel R., White HD., Zeiher AM., Schwartz GG., ODYSSEY OUTCOMES Committees and Investigators
Autorite grupp:Viigimaa M., Soopõld Ü.
Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
PUBMED
Circulation: 140 (2), 103-112, 2019
53Utjes D., Malmstedt J., Teras J., Drzewiecki K., Gullestad HP., Ingvar C., Eriksson H., Gillgren P.
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial
PUBMED
The Lancet: 394 (10197), 471-477, 2019
54Valassi E., Tabarin A., Brue T., Feelders RA., Reincke M., Netea-Maier R., Toth M., Zacharieva S., Webb SM., Tsagarakis S., Chanson P., Pfeiffer M., Droste M., Komerdus I., Kastelan D., Maiter D., Chabre O., Franz H., Santos A., Strasburger CJ., Trainer PJ., Newell-Price J.,2 Ragnarsson O., ERCUSYN Study Group
Autorite grupp:Rudenko P.
High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry
PUBMED
European Journal of Endocrinology: 181 (5), 461-472, 2019
55van der Voort T., Brinkman DJ., Benemei S., Böttiger Y., Chamontin B., Christiaens T., Likic R., Maciulaitis R., Marandi T., Monteiro EC., ...
Appropriate antibiotic prescribing among final-year medical students in Europe
PUBMED
International Journal of Antimicrobial Agents: 54 (3), 375-379, 2019
56Wagner AD., Grabsch HI., Mauer M., Marreaud S., Caballero C., Thuss-Patience P., Mueller L., Elme A., Moehler MH., Martens U., Kang YK., Rha SY., Cats A., Tokunaga M., Lordick F.
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
PUBMED
BMC Cancer: 19, Artikkel nr 494, 2019
57White HD., Steg PG., Szarek M., Bhatt DL., Bittner VA., Diaz R., Edelberg JM., Erglis A., Goodman SG., Hanotin C., Harrington RA., Jukema JW., Lopes RD., Mahaffey KW., Moryusef A., Pordy R., Roe MT., Sritara P., Tricoci P., Zeiher AM., Schwartz GG., ODYSSEY OUTCOMES Investigators
Autorite grupp:Viigimaa M., Soopõld Ü.
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
PUBMED
European Heart Journal: 40 (33), 2801-2809, 2019
Artiklid "Eesti Arstis"
1Anton L.
Kroonilise südamepuudulikkuse diagnoosimine
Eesti Arst: 98 (Lisa 1), 21-27, 2019
2Kaha T.
Külmumuse esmase ravi võimalused ja ravisoovitused
Eesti Arst: 98 (10), 569-576, 2019
3Kampus P.
Kroonilise südamepuudulikkuse resünkroniseeriv ja kardioverter-defibrillaatorravi
Eesti Arst: 98 (Lisa 1), 42-48, 2019
4Laurik J.
Autoimmuunne pankreatiit
Eesti Arst: 98 (8), 472-473, 2019
5Liivak K., Talving P.
Äge mesenteriaalarteri isheemia
Eesti Arst: 98 (7), 390-399, 2019
6Pappa L., Asser A., Lõokene C., Pedak K., Poola M., Nikopensius T., Metspalu A., Paal A.
Seljaajusong ja hüdrotsefaalia: üldine ülevaade ning 30 aastat registriandmete kogumist Eestis
Eesti Arst: 98 (11), 636-644, 2019
7Põder P.
Kroonilise südamepuudulikkuse medikamentoosne ravi
Eesti Arst: 98 (Lisa 1), 34-41, 2019
8Reimand J., Zopp M., Varus H., Kullamaa S., Laanetu ML., Lõokene M., Gross-Paju K., Maron E., Roose Ä., Paris M., Nazarenko S.
Posterioorne kortikaalne atroofia – nägemishäirena avalduva varajase algusega Alzheimeri tõve haigusjuhu kirjeldus
Eesti Arst: 98 (11), 664-668, 2019
9Rips L., Rahu M., Toom A.
Alumise hüppeliigese ehk subtalaarliigese artroskoopiliselt assisteeritud artrodees
Eesti Arst: 98 (3), 153-157, 2019
10Rosembaum O., Viigimaa M.
Telemeditsiinilised lahendused kardioloogiliste haiguste korral
Eesti Arst: 98 (8), 455-460, 2019
11Serg M., Serg M.
Krooniline südamepuudulikkus ja piltdiagnostika
Eesti Arst: 98 (Lisa 1), 28-33, 2019
12Taal G., Merioja I.
Südamevatsakest toetav seade südamepuudulikkuse ravis
Eesti Arst: 98 (Lisa 1), 49-55, 2019
13Uuetoa T., Tammaru M., Põder P.
Kliiniline audit „Südamepuudulikkusega patsientide ravi kvaliteet Eesti haiglates“
Eesti Arst: 98 (Lisa 1), 9-20, 2019
14Vettus R.
Krooniline südamepuudulikkus ja vähk
Eesti Arst: 98 (Lisa 1), 92-97, 2019
Raamatud, dissertatsioonid
1Reile R., Lepp HL., Kiivet RA.
Koduse enteraalse toitmisravi korraldus ja kulud Eestis: tervisetehnoloogia hindamise raport TTH36
Koduse enteraalse toitmisravi korraldus ja kulud Eestis: tervisetehnoloogia hindamise raport TTH36: 56, 2019
2Võhma Ü.
Association between personality traits, clinical characteristics and pharmacological treatment response in panic disorder
Dissertationes medicinae Universitatis Tartuensis: 289, 120, 2019
Kogumikuartiklid, peatükid raamatus
1Holmar J., Fridolin I., Luman M., Jankowski J., Noels H., Jankowski V., Alampour-Rajabi S.
Removal of Vascular Calcification Inducer Phosphate in Different Dialysis Treatment Modalities
IFMBE Proceedings: 68 (3), 143-147, 2019
Konverentsiteesid
1Andreasen LN., Holm NR., Walsh S., Kajander OA., Witt N., Eek C., Knaapen P., Koltowski L., Gutierrez-chico JL., Burzotta F., Bennett J., Laanmets P., Mylotte D., Kumsars I., Christiansen EH.
Rational design and current status on the october trial: a european trial on optical coherence tomography optimized bifurcation event reduction
PhD Day Health, Programme & Abstracts: 84, 2019
2Arjakse J., Malmström R., Allvee M., Gustafsson L., Ilumets H., Kostjuk J., Märk M., Pikta M., Pohanka A., Rönquist Y., Marandi T.
Comparison of anti-FXa chromogenic assay for rivaroxaban used in North Estonia Medical Centre with LC-MS/MS
European Journal of Clinical Pharmacology: 75 (Suppl 1), S26-S27, 2019
3Baum P., Kivik P., Zirel Ü.
Implementation of enhanced recovery protocol (ERP) can reduce postoperative ileus (POI) for patients undergoing radical cystectomy
European Urology Supplements: 18 (3), e2497, 2019
4del Castillo FJ., Munoz G., Ciubotariu C., Gandia M., Rosa JM., Piris M., Gutierrez-Solana LG., Garcia-Silva MT., Palk K., Meneses AG., Grau JM., Fdil N., Sabir E., Slitine N., Sab IA., Bourrahouat A., Rada N., Bouskraoui M., Aldamiz-Echevar LJ., Villarrubia J.
NGS-based, 107-gene resequencing panel as first-line screening test for lysosomal diseases
Molecular Genetics and Metabolism: 126 (2), S47-S48, 2019
5Joost K., Toomsoo T., Rubanovitš I., Kalju I., Ott S., Lindmäe A., Mällo M., Jaakson K., Vender K.
Genetic panel testing in Parkinson's disease
Movement Disorders: 34 (Suppl 2), S178-S179, 2019
6Kõrv J., Antsov K., Gross-Paju K., Kreis A., Liigant A., Vibo R.
Quality improvement programs for stroke in Estonia
European Stroke Journal: 4 (1 Suppl), 672-673, 2019
7Laisaar T., Sarana B., Almre I., Vanakesa T., Benno I., Kibur P., Võrno T.
Surgical treatment of small cell lung cancer (SCLC) in Estonia - nationwide data
27th European Conference on General Thoracic Surgery: 196, 2019
8Lepp HL., Eiche K.
The Assessment of Nutrition Care Practice by Nurses and Doctors of North Estonia Medical Centre
Clinical Nutrition: 38 (Suppl 1), S145-S146, 2019
9Martin-Loeches I., Bruno CJ., Shime N., Wunderink RG.,Kollef M., Kivistik Ü., Novacek M., Rea-Neto A., Timsit JF., Yu B., Huntington JA.,Jensen E., Butterton JR., Rhee EG., Shorr AF.
Outcomes in patients with ventilated nosocomial pneumonia (NP) and organ failure treated with ceftolozane/tazobactam (C/T) vs meropenem (MER) – analysis of the ASPECT-NP randomized, controlled trial
Intensive Care Medicine Experimental: 7 (Suppl 3), 69, 2019
10Mazya M., Cooray C., Carneiro A., Dorado L., Egido JA., Holmin S., Krastev G., Moreira T., Nunes AP., Ollikainen J., Rand VM., Bigliardi G., Zini A., Roffe C., Strbian D., Toni D., Ahmed N.
Endovascular thrombectomy with and without prior intravenous thrombolysis in acute ischemic stroke caused by basilar artery occlusion. Results from the SITS international thrombectomy register
European Stroke Journal: 4 (1 Suppl), 123, 2019
11Märtson M., Tali K., Miidla P.
Sapiteede haigused lastel
Eesti Arst: 98 (Lisa 2), 33, 2019
12Nestal Zibo H., Areda T., Salokorpi N., Serlo W.
Craniosynostoses in Estonia, incidence and management
International Journal of Oral and Maxillofacial Surgery: 48 (Suppl 1), 20, 2019
13Pikta M., Jerjomina J., Kleinson I., Titova T., Reitsnik T.
Evaluation of automated urine sediment analysis for routine use
Clinica Chimica Acta: 493 (Suppl 1), S44, 2019
14Pikta M., Zolotareva V., Banys V.
Implementation of alternative ristocetin reagent on impedance aggregometry analyzer
Clinica Chimica Acta: 493 (Suppl 1), S63-S64, 2019
15Pilt K., Arund J., Adoberg A., Leis L., Fridolin I., Luman M.
Intradialytic on-line multicomponent reduction ratio monitoring in spent dialysate by a novel miniaturized optical sensor
Nephrology Dialysis Transplantation: 34 (Suppl 1), Tees nr SuO012, 2019
16Schneider S., Saapar M., Ringmets I., Vibo R., Kõrv J.
Self-rated health quality in young Estonian stroke patients
European Stroke Journal: 4 (1 Suppl), 576, 2019
17Zemtsovskaja G., Pilt K., Abina J., Meigas K., Viigimaa M.
The Association Of Pulse Wave Velocity With Blood Pressure And Biochemical Cardiovascular Risk Markers In Young Tallinn Adults
Atherosclerosis: 287, e167-e168, 2019
18Torop LA., Kõrv J., Vibo R., Schneider S., Mallene S., Kõrv L.
Estonian young stroke registry: high burden of traditional risk factors and undetermined etiology
European Stroke Journal: 4 (1 Suppl), 607, 2019
19Tõnisson N., Roht L., Palover M., Leitsalu L., Läll K., Fischer K., Kruuv-Käo K., Eelma E., Lehtsaar J., Jürgens H., Kütner R., Valvere V., Nikopensius T., Reigo A., Tammesoo M., Esko T., Metspalu A., Padrik P.
Genotype first female breast cancer risk-based screening and management, initial lessons from a national pilot project
European Journal of Human Genetics: 27 (Suppl 2), 1685, 2019
20Yoo D., Jaworski J., Matyska-Piekarska E., Smiyan S., Ivanova D., Zielinska A., Raussi EK., Batalov A., Lee S., Suh J., Han N., Westhovens R.
A novel formulation of CT-P13 (infliximab biosimilar) for subcutaneous administration: 1-year results from a part 1 of phase I/III randomized controlled trial in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases: 78 (Suppl 2), 733, 2019
Muud publikatsioonid
1Adoberg A.
Haigusjuht: diabeetiline neerukahjustus
Lege Artis: 6 (3), 49-52, 2019
2Ambos A.
Diabeedimaailmas on muutuste aeg
Lege artis: 6 (3), 3, 2019
3Brokk A., Eisen M.
Psoriaas ja kaasuvad haigused
Perearst: 5 (147), 35-38, 2019
4Hanni K.
Pika QT sündroom muudab oluliselt patsiendi elukvaliteeti
Lege Artis: 2 (3), 50-52, 2019
5Härma-Jõks P.
Haigusjuht: Hodkini lümfoomi tõttu saadud keema- ja kiiritusravi hilistüsistused patsiendi südamele
Lege Artis: 5 (3), 31-33, 2019
6Jaagor M.
Bioloogilised ravimid raske astma ravis
Perearst: Bioloogiline ravi, erinumber, 47-54, 2019
7Jaagor M.
Haigusjuht: kroonilise obstruktiivse kopsuhaigusega patsient
Perearst: 2 (144), 63-67, 2019
8Kaha T.
Perearstile haava õmblemisest
Perearst: 6 (148), 16-19, 2019
9Keskpaik T., Kurg K.
Kardiaalse põhjusega rindkerevalu noortel erakorralise meditsiini osakonnas
Perearst: 2 (144), 23-27, 2019
10Laanetu M.
Depressioon ja kognitsioon
Perearst: 6 (148), 47-48, 2019
11Laheäär M.
Kasvaja ja tromboos
Lege Artis: 8 (3), 39-43, 2019
12Lõhmus M.
Bilooglised ravimid ja biosimilar'id onkoloogias
Perearst: Bioloogiline ravi, erinumber, 55-61, 2019
13Meren M.
Ülevaade spirograafiast - kellele, kuidas ja milleks
Lege Artis: 1 (3), 37-42, 2019
14Metsar A.
Krooniline tonsilliit – kas ja millal opereerida?
Perearst: 1 (143), 62-63, 2019
15Märk M.
Sepsis ja septiline šokk – seisundi äratundmine, ravi ja ennetamine uue ravijuhendi põhjal
Perearst: 08 (150), 62-64, 2019
16Märk M.
Südame amüloidoos
Lege Artis: 5 (3), 25-28, 2019
17Oro I.
Eetika ja seaduse konfliktist
Eesti Arst: 98 (9), 487, 2019
18Oro I.
Euroopa Arstide Liit tuli kokku Maltal
Eesti Arst: 98 (5), 252-253, 2019
19Rinne I., Kütt M.
Sagedamini esinevad toiduainetest põhjustatud tervisehäired ja nende laboratoorne diagnostika
Perearst: 10 (152), 48-51, 2019
20Schneider S., Kõrv J.
Insuldi ravivõimalused on avardunud
Lege Artis: 3 (3), 25-27, 2019
21Serg M., Viigimaa M.
Kardiovaskulaarsete tüsistuste ennetamine uudsete diabeediravimitega 2. tüüpi diabeediga patsientidel
Perearst: 4 (146), 37-45, 2019
22Serg M., Viigimaa M.
Kardiovaskulaarsete tüsistuste ennetamine uudsete diabeediravimitega 2. tüüpi diabeediga patsientidel
Lege Artis: 6 (3), 11-21, 2019
23Sergejeva S.
Raske astma käsitlus täiskasvanutel
Perearst: 09 (151), 77-81, 2019
24Suuroja T.
Jämesoolevähi diagnoosimine ja ravivõimalused
Lege Artis: 4 (3), 23-27, 2019
25Teras M.
Haigusjuht: melanoomi areng gigantse kongenitaalse neevuse foonil
Lege Artis: 4 (3), 56-59, 2019
26Toim E.
Tööga seotud kopsuhaigused
Perearst: 10 (152), 21-24, 2019
27Toim E.
Tööga seotud kopsuhaigused on Eestis aladiagnoositud
Lege Artis: 2 (3), 25-28, 2019
28Vaide I.
Kaasasündinud veritsushaigused
Lege Artis: 2 (3), 20-23, 2019
29Valvere V.
Vähiga toimetulemisesks vajame kõigi panust
Lege Artis: 4 (3), 3, 2019
30Vettus E.
IV rahvusvaheline levinud rinnavähi konsensusjuhend
Lege Artis: 4 (3), 9-11, 2019
31Vettus E.
Rinnavähk ja hormonaalsed kontratseptiivid – on seal seos?
Perearst: 3 (145), 94-96, 2019
32Viigimaa I.
Krooniline lümfotsüütleukeemia muutuste tuules
Lege Artis: 7 (3), 29-31, 2019
33Viigimaa M.
Bioloogiline ravi hüperlipideemia korral
Perearst: Bioloogiline ravi, erinumber, 39-43, 2019
34Viigimaa M.
Noppeid uuendatud kõrgvererõhktõve juhendist
Perearst: 10 (152), 35-39, 2019
35Viks L.
Kroonilise obstruktiivse kopsuhaiguse kolmikravi
Perearst: 08 (150), 51-53, 2019